Department of Internal Medicine and Specialties, Faculty of Medicine and Biomedical Sciences, University of Yaounde I, Yaounde, Cameroon
Department of Internal Medicine and Specialties, Faculty of Medicine and Biomedical Sciences, University of Yaounde I, Yaounde, Cameroon.
J Investig Med. 2020 Aug;68(6):1193-1195. doi: 10.1136/jim-2019-001267. Epub 2020 Jul 14.
This study was carried out to assess the potential reduction in duration of intensive diabetic ketoacidosis treatment in adults with ketosis-prone atypical diabetes (KPD) when using capillary versus urinary ketones. In this cross-sectional study, we included 20 people with KPD presented at the National Obesity Center of the Yaoundé Central Hospital with hyperglycemic decompensation (random capillary glucose ≥13 mmol/L) and significant ketosis (ketonuria≥++) requiring intensive insulin treatment. In all subjects, intensive insulin treatment was initiated at 10 UI per hour with simultaneous measurement of capillary beta-hydroxybutyrate and ketonuria every 2 hours until disappearance of ketonuria. Time-to-disappearance of urine ketones was compared with the time-to-normalization of capillary β-hydroxybutyrate concentrations. Subjects were aged 46±13 years with a median duration of diabetes of 1.5 (IQR: 0-2.5) years. On admission, the mean blood glucose was 22.8±5 mmol/L and capillary ketones level was 2.9±2.7 mmol/L. The median time-to-disappearance of ketonuria was 5 (IQR: 3-8) hours compared with the time-to-normalization of capillary β-hydroxybutyrate of 4 (IQR: 2-6) hours, p=0.0002. The absolute difference in time-to-normalization of ketonuria versus ketonemia was 2 (IQR: 1-3) hours and the relative time reduction of treatment was 32.5%±18.0%. Our results suggested that the use of capillary ketones versus ketonuria would allow a significant reduction in duration of intensive insulin treatment by one third in people with KPD.
本研究旨在评估在有酮症倾向的非典型糖尿病(KPD)患者中使用毛细血管与尿酮体时,将强化糖尿病酮症酸中毒治疗时间缩短的可能性。在这项横断面研究中,我们纳入了 20 名在雅温得中央医院国家肥胖中心就诊的 KPD 患者,他们有高血糖失代偿(随机毛细血管血糖≥13mmol/L)和明显的酮症(酮尿症≥+++),需要强化胰岛素治疗。所有患者均以每小时 10UI 的初始剂量开始强化胰岛素治疗,同时每 2 小时测量一次毛细血管β-羟丁酸和尿酮体,直到酮尿症消失。将尿酮体消失时间与毛细血管β-羟丁酸浓度正常化时间进行比较。受试者年龄为 46±13 岁,糖尿病病程中位数为 1.5(IQR:0-2.5)年。入院时,平均血糖为 22.8±5mmol/L,毛细血管酮体水平为 2.9±2.7mmol/L。尿酮体消失的中位数时间为 5(IQR:3-8)小时,而毛细血管β-羟丁酸正常化时间为 4(IQR:2-6)小时,p=0.0002。酮尿症与酮血症正常化时间的绝对差异为 2(IQR:1-3)小时,治疗时间相对减少 32.5%±18.0%。我们的结果表明,与使用尿酮体相比,使用毛细血管酮体可使 KPD 患者强化胰岛素治疗时间缩短三分之一。